Innovations in Obesity Treatment: Focus on Retatrutide and GLP-1 Agonists | Retatrutide News

Retatrutide, a GLP-1 agonist, is part of the advancements in obesity management. Eli Lilly's pipeline includes this drug, highlighting its potential imp...
Weight Loss · October 11, 2026